Physician profile
William Bickers
NPI 1114311073
$5,065.68
in general payments reported to CMS, 2019-2025
17 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $409 · 2021: $489 · 2022: $543 · 2023: $580 · 2024: $2,451 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,787 · Travel and Lodging: $1,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.05 |
| Travel and Lodging | $1,592.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,076.78 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $899.95 | 2020-2024 | Senza |
| Boston Scientific Corporation | $467.90 | 2019-2025 | Intracept |
| Medtronic, INC. | $398.98 | 2022-2024 | Intellis Adaptivestim, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $364.35 | 2021-2024 | Relistor |
| Abbott Laboratories | $167.28 | 2023-2025 | Eterna, Octrode, Ionicrf |
| Abbvie INC. | $161.33 | 2023-2025 | Qulipta, Ubrelvy |
| Mallinckrodt Enterprises LLC | $120.12 | 2019 | |
| Collegium Pharmaceutical, INC. | $83.62 | 2021-2023 | Belbuca |
| Hikma Pharmaceuticals USA | $68.18 | 2022 | |
| Globus Medical, INC. | $61.42 | 2025 | Senza |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Pacira Therapeutics, INC. | $43.10 | 2020-2021 | |
| Protega Pharmaceutials INC | $40.23 | 2022 | |
| Si-Bone, INC. | $32.49 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $17.26 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bickers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.